The Current Ratio as of November 2024 (TTM) for Celcuity Inc. (CELC) is 14.95

According to Celcuity Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.95. This represents a change of 17.80% compared to the average of 12.69 of the last 4 quarters.

Celcuity Inc. (CELC) Historical Current Ratio (quarterly & annually)

How has CELC Current Ratio performed in the past?

The mean historical Current Ratio of Celcuity Inc. over the last ten years is 24.01. The current 14.95 Current Ratio has changed 6.13% with respect to the historical average. Over the past ten years (40 quarters), CELC's Current Ratio was at its highest in in the September 2017 quarter at 97.71. The Current Ratio was at its lowest in in the June 2001 quarter at 0.

Celcuity Inc. (CELC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Celcuity Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Celcuity Inc. (CELC) Average Current Ratio

How has CELC Current Ratio performed in the past?

The current Current Ratio of Celcuity Inc. (CELC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Celcuity Inc. (CELC) Current Ratio vs. Peers

How is CELC’s Current Ratio compared to its peers?

Celcuity Inc.’s Current Ratio is greater than Werewolf Therapeutics, Inc. (12.13), less than Edgewise Therapeutics, Inc. (30.24), greater than Decibel Therapeutics, Inc. (3.03), greater than C4 Therapeutics, Inc. (6.31), greater than Anebulo Pharmaceuticals, Inc. (13.46), greater than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (16.16), greater than AnaptysBio, Inc. (9.09), greater than Mineralys Therapeutics, Inc. (11.20), greater than Molecular Partners AG (14.58), less than MediciNova, Inc. (18.24), greater than Champions Oncology, Inc. (0.69), less than Cyteir Therapeutics, Inc. (21.89), less than Ikena Oncology, Inc. (18.22), greater than Rezolute, Inc. (13.39), greater than Aerovate Therapeutics, Inc. (6.51), greater than AN2 Therapeutics, Inc. (10.61),

Build a custom stock screener for Celcuity Inc. (CELC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celcuity Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Celcuity Inc. (CELC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Celcuity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.